2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide

Star0

DB02036ExperimentalSmall molecule

2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide: Overview.

Formula / weight: C₁₀H₁₀N₂O₃S · 238.263 g/mol (avg)

Resolves to

Compound

PubChem448475

Structure

InChIKeyUKDWCJNGBPZOBU-MRVPVSSYSA-NSMILES[H][C@]1(CC(=O)NO)SC2=CC=CC=C2NC1=O

Targets

Q9I7A8def

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with 2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account